These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 20800067)

  • 1. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade.
    Reinkober J; Tscheschner H; Pleger ST; Most P; Katus HA; Koch WJ; Raake PW
    Gene Ther; 2012 Jun; 19(6):686-93. PubMed ID: 22336718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.
    Ciccarelli M; Chuprun JK; Rengo G; Gao E; Wei Z; Peroutka RJ; Gold JI; Gumpert A; Chen M; Otis NJ; Dorn GW; Trimarco B; Iaccarino G; Koch WJ
    Circulation; 2011 May; 123(18):1953-62. PubMed ID: 21518983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
    Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
    Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
    J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inotropic peptide βARKct improves βAR responsiveness in normal and failing cardiomyocytes through G(βγ)-mediated L-type calcium current disinhibition.
    Völkers M; Weidenhammer C; Herzog N; Qiu G; Spaich K; Wegner FV; Peppel K; Müller OJ; Schinkel S; Rabinowitz JE; Hippe HJ; Brinks H; Katus HA; Koch WJ; Eckhart AD; Friedrich O; Most P
    Circ Res; 2011 Jan; 108(1):27-39. PubMed ID: 21106943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.
    Rengo G; Galasso G; Femminella GD; Parisi V; Zincarelli C; Pagano G; De Lucia C; Cannavo A; Liccardo D; Marciano C; Vigorito C; Giallauria F; Ferrara N; Furgi G; Filardi PP; Koch WJ; Leosco D
    Eur J Prev Cardiol; 2014 Jan; 21(1):4-11. PubMed ID: 23689525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
    Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
    Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.
    Brinks H; Boucher M; Gao E; Chuprun JK; Pesant S; Raake PW; Huang ZM; Wang X; Qiu G; Gumpert A; Harris DM; Eckhart AD; Most P; Koch WJ
    Circ Res; 2010 Oct; 107(9):1140-9. PubMed ID: 20814022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart.
    Pfleger J; Gross P; Johnson J; Carter RL; Gao E; Tilley DG; Houser SR; Koch WJ
    J Mol Cell Cardiol; 2018 Oct; 123():108-117. PubMed ID: 30171848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy.
    Cannavo A; Liccardo D; Koch WJ
    Front Physiol; 2013 Sep; 4():264. PubMed ID: 24133451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRK2 in the heart: a GPCR kinase and beyond.
    Huang ZM; Gao E; Chuprun JK; Koch WJ
    Antioxid Redox Signal; 2014 Nov; 21(14):2032-43. PubMed ID: 24702056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor kinases in normal and failing myocardium.
    Huang ZM; Gold JI; Koch WJ
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3047-60. PubMed ID: 21622221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure.
    Rengo G; Pagano G; Paolillo S; de Lucia C; Femminella GD; Liccardo D; Cannavo A; Formisano R; Petraglia L; Komici K; Rengo F; Trimarco B; Ferrara N; Leosco D; Perrone-Filardi P
    Eur J Clin Invest; 2015 Feb; 45(2):187-95. PubMed ID: 25545706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
    Swain JD; Fargnoli AS; Katz MG; Tomasulo CE; Sumaroka M; Richardville KC; Koch WJ; Rabinowitz JE; Bridges CR
    J Cardiovasc Transl Res; 2013 Apr; 6(2):253-62. PubMed ID: 23208013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.